Home Healthcare IT United Kingdom Cell and Gene Therapy Manufacturing QC Market Size & Growth | 2033

United Kingdom Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, CAR-T, CAR-NK, B-Cell, Others, Gene Therapy, Viral, Non-viral), By Scale (Pre-commercial/ R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-house Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Raw Material Testing, Vector Production, Other Workflows), By Process (Upstream Processes, Downstream Processes), By End-User (Pharmaceutical Companies, Biopharmaceutical / Biotechnological Companies, Contract Manufacturing Organizations), By Technology Type (Fluorescence-Activated Cell Sorting (FACS), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others) and Forecasts, 2025-2033

Report Code: SRHI56481DR
Last Updated : Oct 21, 2024
Author : Debashree Bora
Starting From
USD 1850
Buy Now

Market Segmentation

  1. United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Therapy Type (2021-2033)
    1. Cell Therapy
    2. CAR-T
    3. CAR-NK
    4. B-Cell
    5. Others
    6. Gene Therapy
    7. Viral
    8. Non-viral
  2. United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Scale (2021-2033)
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Mode (2021-2033)
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Workflow (2021-2033)
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Process (2021-2033)
    1. Upstream Processes
    2. Downstream Processes
  6. United Kingdom Cell and Gene Therapy Manufacturing QC Market, By End-User (2021-2033)
    1. Pharmaceutical Companies
    2. Biopharmaceutical / Biotechnological Companies
    3. Contract Manufacturing Organizations
  7. United Kingdom Cell and Gene Therapy Manufacturing QC Market, By Technology Type (2021-2033)
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others

Related Reports

Global Report
Cell and Gene Therapy Market Size The global cell and gene therapy market size was valued at USD 30.27 billion in 2024 and is projected to reach from USD 37.14 billion in 2025 to USD 190.82 billion by 2033, expanding at a CAGR of 22.7% from 2025 to
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :